Cargando…
Communicating about COVID-19 vaccine development and safety
PURPOSE: Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages des...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355181/ https://www.ncbi.nlm.nih.gov/pubmed/35930557 http://dx.doi.org/10.1371/journal.pone.0272426 |
_version_ | 1784763235132506112 |
---|---|
author | Thorpe, Alistair Fagerlin, Angela Butler, Jorie Stevens, Vanessa Drews, Frank A. Shoemaker, Holly Riddoch, Marian S. Scherer, Laura D. |
author_facet | Thorpe, Alistair Fagerlin, Angela Butler, Jorie Stevens, Vanessa Drews, Frank A. Shoemaker, Holly Riddoch, Marian S. Scherer, Laura D. |
author_sort | Thorpe, Alistair |
collection | PubMed |
description | PURPOSE: Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages designed to address these beliefs and concerns might promote intentions to get a COVID-19 vaccine. METHOD: We conducted an online survey fielded between March 8–23, 2021 with US Veteran (n = 688) and non-Veteran (n = 387) respondents. In a between-subjects experiment, respondents were randomly assigned to a control group (with no message) or to read one of two intervention messages: 1. a fact-box styled message comparing the risks of getting COVID-19 compared to the vaccine, and 2. a timeline styled message describing the development process of the COVID-19 mRNA vaccines. RESULTS: Most respondents (60%) wanted a COVID-19 vaccine. However, 17% expressed hesitancy and 23% did not want to get a COVID-19 vaccine. The fact-box styled message and the timeline message did not significantly improve vaccination intentions, F(2,358) = 0.86, p = .425, [Image: see text] = .005, or reduce the time respondents wanted to wait before getting vaccinated, F(2,306) = 0.79, p = .453, [Image: see text] = .005, compared to no messages. DISCUSSION: In this experimental study, we did not find that providing messages about vaccine risks and the development process had an impact on respondents’ vaccine intentions. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions. |
format | Online Article Text |
id | pubmed-9355181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-93551812022-08-06 Communicating about COVID-19 vaccine development and safety Thorpe, Alistair Fagerlin, Angela Butler, Jorie Stevens, Vanessa Drews, Frank A. Shoemaker, Holly Riddoch, Marian S. Scherer, Laura D. PLoS One Research Article PURPOSE: Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages designed to address these beliefs and concerns might promote intentions to get a COVID-19 vaccine. METHOD: We conducted an online survey fielded between March 8–23, 2021 with US Veteran (n = 688) and non-Veteran (n = 387) respondents. In a between-subjects experiment, respondents were randomly assigned to a control group (with no message) or to read one of two intervention messages: 1. a fact-box styled message comparing the risks of getting COVID-19 compared to the vaccine, and 2. a timeline styled message describing the development process of the COVID-19 mRNA vaccines. RESULTS: Most respondents (60%) wanted a COVID-19 vaccine. However, 17% expressed hesitancy and 23% did not want to get a COVID-19 vaccine. The fact-box styled message and the timeline message did not significantly improve vaccination intentions, F(2,358) = 0.86, p = .425, [Image: see text] = .005, or reduce the time respondents wanted to wait before getting vaccinated, F(2,306) = 0.79, p = .453, [Image: see text] = .005, compared to no messages. DISCUSSION: In this experimental study, we did not find that providing messages about vaccine risks and the development process had an impact on respondents’ vaccine intentions. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions. Public Library of Science 2022-08-05 /pmc/articles/PMC9355181/ /pubmed/35930557 http://dx.doi.org/10.1371/journal.pone.0272426 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Thorpe, Alistair Fagerlin, Angela Butler, Jorie Stevens, Vanessa Drews, Frank A. Shoemaker, Holly Riddoch, Marian S. Scherer, Laura D. Communicating about COVID-19 vaccine development and safety |
title | Communicating about COVID-19 vaccine development and safety |
title_full | Communicating about COVID-19 vaccine development and safety |
title_fullStr | Communicating about COVID-19 vaccine development and safety |
title_full_unstemmed | Communicating about COVID-19 vaccine development and safety |
title_short | Communicating about COVID-19 vaccine development and safety |
title_sort | communicating about covid-19 vaccine development and safety |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355181/ https://www.ncbi.nlm.nih.gov/pubmed/35930557 http://dx.doi.org/10.1371/journal.pone.0272426 |
work_keys_str_mv | AT thorpealistair communicatingaboutcovid19vaccinedevelopmentandsafety AT fagerlinangela communicatingaboutcovid19vaccinedevelopmentandsafety AT butlerjorie communicatingaboutcovid19vaccinedevelopmentandsafety AT stevensvanessa communicatingaboutcovid19vaccinedevelopmentandsafety AT drewsfranka communicatingaboutcovid19vaccinedevelopmentandsafety AT shoemakerholly communicatingaboutcovid19vaccinedevelopmentandsafety AT riddochmarians communicatingaboutcovid19vaccinedevelopmentandsafety AT schererlaurad communicatingaboutcovid19vaccinedevelopmentandsafety |